Company page

Cel-sci Corporation

Cel-sci Corporation, traded under the ticker CVM, is a public company based in America with a market capitalization of approximately $20.6 million. The company is focused on developing innovative therapies for cancer and other diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.